Nuzenio

Advanced Mesothelioma

Advanced Mesothelioma news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Australian company points to encouraging survival signal in mesothelioma CAR-T study - BiotechDispatchBiotechDispatch · Mon, 10 Aug 2026 08:35:18 GMTMesothelioma Patient Remains Cancer-Free Two Years After Single CAR T Cell Treatment - Mesothelioma.netMesothelioma.net · Wed, 05 Aug 2026 15:29:01 GMTAdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - BiotechDispatchBiotechDispatch · Wed, 05 Aug 2026 09:32:35 GMTInsilico Medicine to Present AI-Designed Drug for Mesothelioma Treatment, FDA to Fast-Track - mesotheliomaguide.commesotheliomaguide.com · Thu, 30 Jul 2026 07:00:00 GMTFDA Grants Fast Track Designation to ISM6331 for Advanced Mesothelioma - Targeted OncologyTargeted Oncology · Wed, 29 Jul 2026 07:00:00 GMTInsilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma - Insilico MedicineInsilico Medicine · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Mon, 10 Aug 2026 08:35:18 GMTAustralian company points to encouraging survival signal in mesothelioma CAR-T study - BiotechDispatch
Wed, 05 Aug 2026 15:29:01 GMTMesothelioma Patient Remains Cancer-Free Two Years After Single CAR T Cell Treatment - Mesothelioma.net
Wed, 05 Aug 2026 09:32:35 GMTAdAlta reports two year cancer free survival after single dose of experimental mesothelioma therapy - BiotechDispatch
Thu, 30 Jul 2026 07:00:00 GMTInsilico Medicine to Present AI-Designed Drug for Mesothelioma Treatment, FDA to Fast-Track - mesotheliomaguide.com
Wed, 29 Jul 2026 07:00:00 GMTFDA Grants Fast Track Designation to ISM6331 for Advanced Mesothelioma - Targeted Oncology
Tue, 28 Jul 2026 07:00:00 GMTInsilico Medicine Receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in Advanced Mesothelioma - Insilico Medicine

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Advanced Mesothelioma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.